SLC31A1 and lung carcinoma: Among these five CRRs, SLC31A1 was associated with chemoresistance to platinum in osteosarcoma (Cheng et al., 2020), lung cancer (Wang et al., 2021b), and ovarian cancer (Wu et al., 2021b).